NCT04990765

Brief Summary

The pilot study is a single-blinded, randomized, controlled, 2 months clinical trial. The objective is to investigate the feasibility, effects and side-effects of virtual reality-assisted cognitive behavioral therapy (VR-CBT) vs. cognitive behavioral therapy (CBT) on alcohol intake in patients with a diagnosis of alcohol dependence.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started May 2021

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 15, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 4, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2021

Completed
Last Updated

August 4, 2021

Status Verified

July 1, 2021

Enrollment Period

5 months

First QC Date

June 15, 2021

Last Update Submit

July 27, 2021

Conditions

Keywords

AlcoholAddictionVirtual RealityExposure TherapyCognitive Behavioral Therapy

Outcome Measures

Primary Outcomes (1)

  • Reduction in total alcohol consumption

    Percent reduction in alcohol consumption, defined as "x" grams of alcohol for past 30 days. This will be registered using the Timeline-Follow-Back (TLFB) method.

    From baseline to 1 week and 1 month after the third and final treatment session

Secondary Outcomes (11)

  • Reduction in heavy drinking days

    Baseline,1 week and 1 month follow-up

  • Reduction in Alcohol Users Identification Test (AUDIT) score

    Baseline, 1 week and 1 month follow-up

  • Reduction in Drug User Identification Test (DUDIT) score

    Baseline, 1 week and 1 month follow-up

  • Reduction in Penn Alcohol Craving Scale (PACS) score

    Baseline, 1 week and 1 month follow-up

  • Screening for Cognitive Impairment in Psychiatry (SCIP) score

    Baseline, 1 week and 1 month follow-up

  • +6 more secondary outcomes

Study Arms (2)

Virtual Reality Cognitive Behavioral Therapy (VRCBT)

EXPERIMENTAL

The VR exposure is performed to induce alcohol craving during the therapy session, in order to trigger a lifelike response to alcohol, while the therapist is present and able to train the participant in applying CBT-based coping strategies to deal with the alcohol cravings.

Behavioral: Virtual Reality Cognitive Behavioral Therapy (CRAVR)

Cognitive Behavioral Therapy (CBT)

ACTIVE COMPARATOR

CBT is made up of the following elements: i) recognition (ii) avoiding and (iii) overcoming drinking cravings in high-risk situations with the aim of preventing relapse.

Behavioral: CBT

Interventions

Participants in the intervention group will scheduled for 3 weekly treatment sessions based on manualized cognitive behavioral therapy assisted with alcohol-related high risk situations (6 different scenes from a restaurant) in virtual reality. From scene 1 to scene 6, alchol-related cues increase in intensity in order to perform gradual exposure therapy as a part of CBT. Furthermore, VR scenes are used in CBT to induce craving for coping strategy skill training and cognitive analysis.

Virtual Reality Cognitive Behavioral Therapy (VRCBT)
CBTBEHAVIORAL

The active comparator receives 3 conventional cognitive behavioral therapy sessions with 1 week intervals.

Cognitive Behavioral Therapy (CBT)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed oral and written consent
  • Meets criteria for alcohol dependence syndrome according to International Classification of Diseases (ICD) 10, WHO \& Diagnostic and Statistical Manual of Mental Disorder (DSM-5)
  • Age 18 - 70 years old (both included)
  • Minimum 5 'heavy drinking days' in the last month, which is defined as an alcohol intake above 60/48 grams or 5/4 items per. day for resp. men and women over the past 30 days

You may not qualify if:

  • Other active substance use defined by DUDIT score\> 6 (for men)\> 2 (for women) and meet the criteria for other drug dependence according to ICD-10 (excluding nicotine)
  • Does not speak or understand Danish
  • Mental retardation or known severe psychiatric illness or other condition where it is assessed that will interfere with participation eg severely impaired vision or hearing.
  • Medical alcohol treatment (disulfiram, acamprosate, naltrexone or nalmefen) within the latest 4 weeks and during the treatment period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Novavi ambulatorierne

Copenhagen, Frederiksberg, 2000, Denmark

RECRUITING

Related Publications (1)

  • Thaysen-Petersen D, Hammerum SK, Vissing AC, Oestrich IH, Nordentoft M, During SW, Fink-Jensen A. Virtual reality-assisted cognitive behavioral therapy for patients with alcohol use disorder: a randomized feasibility study. Front Psychiatry. 2024 Feb 14;15:1337898. doi: 10.3389/fpsyt.2024.1337898. eCollection 2024.

MeSH Terms

Conditions

AlcoholismBehavior, Addictive

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersCompulsive BehaviorImpulsive BehaviorBehavior

Central Study Contacts

Anders Fink-Jensen, MD, DMSc

CONTACT

Daniel Thaysen Petersen, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: single-blinded, randomized, controlled
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MD, DMSci

Study Record Dates

First Submitted

June 15, 2021

First Posted

August 4, 2021

Study Start

May 11, 2021

Primary Completion

October 20, 2021

Study Completion

October 20, 2021

Last Updated

August 4, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations